Linnemayr Sebastian, Huang Haijing, Luoto Jill, Kambugu Andrew, Thirumurthy Harsha, Haberer Jessica E, Wagner Glenn, Mukasa Barbara
Sebastian Linnemayr, Jill Luoto, and Glenn Wagner are with the RAND Corporation, Santa Monica, CA. Haijing Huang is with the Pardee RAND Graduate School, Santa Monica. Andrew Kambugu is with Infectious Diseases Institute and Makerere University, Kampala, Uganda. Harsha Thirumurthy is with Department of Health Policy and Management and Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. Jessica E. Haberer is with Massachusetts General Hospital Center for Global Health and Harvard Medical School, Boston, MA. Barbara Mukasa is with Mildmay Uganda, Kampala.
Am J Public Health. 2017 Dec;107(12):1944-1950. doi: 10.2105/AJPH.2017.304089. Epub 2017 Oct 19.
To assess the effectiveness of Short Message Service (SMS) reminder messages on antiretroviral and cotrimoxazole prophylaxis adherence among HIV-positive youths as well as the relative effectiveness of SMS with and without a response option.
Eligible HIV-positive patients aged 15 to 22 years at 2 HIV clinics in Kampala, Uganda, participated in a year-long parallel individual-randomized controlled trial and were assigned in a 1-to-1-to-1 ratio to a weekly SMS message group, weekly SMS message with response option group, or a usual-care control group.
We enrolled 332 participants. Electronically measured mean adherence was 67% in the control group, 64% in the 1-way SMS group (95% confidence interval [CI] = 0.77, 1.14), and 61% in the 2-way SMS group (95% CI = 0.75, 1.12) in an intent-to-treat analysis. Results for secondary outcomes and complete-case analysis were similarly statistically insignificant across groups.
Despite previous evidence that interventions using SMS reminders can promote antiretroviral therapy adherence, this study shows that they are not always effective in achieving behavior change. More research is needed to find out for whom, and under what conditions, they can be beneficial.
ClinicalTrials.gov identifier: NCT00830622.
评估短信提醒对艾滋病毒阳性青年抗逆转录病毒和复方新诺明预防用药依从性的有效性,以及有无回复选项的短信的相对有效性。
乌干达坎帕拉两家艾滋病毒诊所中年龄在15至22岁的符合条件的艾滋病毒阳性患者参加了一项为期一年的平行个体随机对照试验,并以1:1:1的比例被分配到每周短信组、有回复选项的每周短信组或常规护理对照组。
我们招募了332名参与者。在意向性分析中,对照组电子测量的平均依从性为67%,单向短信组为64%(95%置信区间[CI]=0.77,1.14),双向短信组为61%(95%CI=0.75,1.12)。各亚组次要结局和完整病例分析的结果在统计学上同样无显著差异。
尽管之前有证据表明使用短信提醒的干预措施可以提高抗逆转录病毒治疗的依从性,但本研究表明,它们并非总能有效实现行为改变。需要更多研究来确定对谁以及在何种条件下它们会有益。
ClinicalTrials.gov标识符:NCT00830622。